Terbutaline as a treatment for premature labour is an off-label use not approved by the FDA. It is a pregnancy category 'B' medication and is routinely prescribed to stop contractions. Terbutaline is currently on the World Anti-Doping Agency's list of prohibited drugs, except, when administered by inhalation, a Therapeutic Use Exemption (TUE) has been obtained in advance.